A vital leap forward in cardiac testing

When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care—producing accurate results in just 8 minutes—could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories. 

Features & Benefits

Simple to use and easily integrated into existing systems, the Atellica® VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, delivers accurate, clinically actionable high-sensitivity troponin I results directly in the hands of those who need it most. 

Improved ED throughput

The Atellica VTLi system streamlines chest pain assessment, aiding in earlier dispostion decisions for patients not having an MI and fast interventions for those who are.

Evidence-based, accurate performance

The Atellica VTLi system offers hs-cTnI testing right at the point of care. Results are available in just minutes for clinicians and laboratry partner.

Easily integrated into assesment processes

The Atellica VTLi system will aid in transforming your chest pain assesment process to benefit patients, clinicians, and opertaional workflow.

More Information Here